First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001) - Concepedia

Concepedia

Publication | Open Access

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)

DOI Full Paper Access

168

Citations

28

References

2012

Year

Lindsey R. Baden, Stephen R. Walsh, Michael S. Seaman, Robert Tucker, Kathleen H. Krause, Alka Patel, Jennifer Johnson, Jane A. Kleinjan, Katherine E. Yanosick, James Perry,

The Journal of Infectious Diseases

Abstract

NCT00618605.

References

	Year	Citations

Page 1